Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
NiroWell is an Israeli medical technology company focused on developing a non-invasive system for monitoring intracranial pressure (ICP). The company's primary goal is to replace current invasive monitoring methods, which require surgical insertion of a probe into the brain, with a safe and continuous non-invasive alternative. Utilizing advanced sensors and proprietary algorithms, NiroWell's technology is designed for use in intensive care units and emergency settings to manage patients with traumatic brain injury, stroke, and other neurological conditions. The company aims to provide real-time, accurate data that can improve clinical decision-making and patient outcomes in neurocritical care. NiroWell is backed by Alon MedTech Ventures and led by experienced entrepreneurs in the medical device space.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on NiroWell.